登录 | 注册    关注公众号  
微信公众号
搜索
 > 【TGF-beta 3】

TGF-beta 3信息

英文名称:Transforming growth factor beta 3
中文名称:转化生长因子β3
靶点别称:Transforming Growth Factor beta3,TGFB3,LAP,Prepro-Transforming Growth Factor Beta-3,TGF-Beta3,Transforming Growth Factor, Beta 3,ARVD1,LDS5,Arrhythmogenic Right Ventricular Dysplasia 1,RNHF,Transforming growth factor beta-3 proprotein,ARVD
上市药物数量:0
临床药物数量:3
最高研发阶段:临床二期

TGF-beta 3分子别名

TGFB3,ARVD,TGF-beta3

TGF-beta 3分子背景

Transforming growth factor beta 3 ( TGFB3) is also known as TGF-β3, is a polypeptide member of the transforming growth factor beta superfamily of cytokines. It is a secreted protein that performs many cellular functions, including regulates embryogenesis and cell differentiation and is required in various processes such as secondary palate development. TGF-beta 3 is similar with TGF-beta 1 and ­-beta 2, act as cellular switches to regulate immune function, cell proliferation, and epithelial­-mesenchymal transition. TGF-beta-3 is released from LAP by integrins: integrin-binding results in distortion of the LAP chain and subsequent release of the active TGF-beta-3. Once activated following release of LAP, TGF-beta-3 acts by binding to TGF-beta receptors (TGFBR1 and TGFBR2), which transduce signal.

TGF-beta 3临床药物信息

英文名称 研发代码 研发阶段 公司 适应症 临床试验
AVID-200 AVID-200; BMS-986416; AVID-200 DP 临床一期 Formation Biologics Corp 实体瘤, 真性红细胞增多症, 骨髓纤维化, 弥漫性硬皮病, 原发性血小板增多症 详情
Dalutrafusp alfa AGEN-1423; GS-1423 临床二期 Gilead Inc, 安帝君斯公司 实体瘤, 胰腺癌, 胰腺导管癌 详情
RG-6315 RG-6315 临床一期 基因泰克 系统性硬皮病 详情

消息提示

请输入您的联系方式,再点击提交!

确定